Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Treatment of myelodysplastic syndromes in elderly patients.

    ... age or comorbidities at diagnosis or lack of a human leukocyte antigen-identical donor. MDS in the elderly should be managed ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.

    ... 6p arms (6pLOH). The 6pLOH commonly involved the human leukocyte antigen ( HLA ) locus, leading to loss of one HLA ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?

    ... unrelated donor . For patients who lack an human leukocyte antigen -compatible donor, autologous SCT, or chemotherapy ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Telomere length in myelodysplastic syndromes

    ... (MDS) remains unclear. We compared peripheral blood leukocyte (PBL) TL among cases of histologically confirmed MDS (n = 65) ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

    ... or PBPC (n = 71) from unrelated donors matched at human leukocyte antigen -A, -B, -C, -DRB1. Hematopoietic recovery was similar ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Alternative donor transplantation for aplastic anemia.

    ... severe aplastic anemia who do not have a human leukocyte antigen ( HLA )-identical sibling generally receive ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.

    ... of Health from 2000 to 2008. The pretreatment leukocyte age-adjusted telomere length of patients with severe aplastic ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Alternative donor HSCT in refractory acquired aplastic anemia - Prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation

    ... cells. All patients engrafted rapidly. Median time to leukocyte engraftment was 10 days. With a median follow-up of 26 ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Somatic HLA mutations expose the role of class I–mediated autoimmunity in aplastic anemia and its clonal complications

    ... is unknown, aAA is thought to be driven by human leukocyte antigen ( HLA )–restricted T cell immunity, with ...

    Research Article last updated 10/23/2017 - 10:56am.

  10. Approved: New blood cancer detection tool

    ... is specific to CD45, which is expressed on a variety of leukocyte populations. This marker is used as a gating agent for the tests, ...

    Article last updated 07/05/2017 - 10:30am.